MGNX vs PG · rev $149.5M vs P/E 25, rev $84.28B
MacroGenics Inc (MGNX) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported MGNX revenue for 2025-12-31 was $149.5M. Net income was -$74.6M. Revenue was down 0.3% from 2024-12-31 to 2025-12-31. MGNX currently screens at market cap $246.6M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
MGNX currently screens at market cap $246.6M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the MGNX and PG stock pages for the full models.
Not investment advice.